Medaphor Group PLC Patent Infringement Settlement (0517S)
16 December 2016 - 6:24PM
UK Regulatory
TIDMMED
RNS Number : 0517S
Medaphor Group PLC
16 December 2016
MedaPhor Group plc
("the Group" the "Company")
Patent Infringement Settlement
Further to the statement made by the Company on 27 April 2016
(RNS No. 4638W: Notice of Patent Infringement Proceedings), the
Group subsidiaries, MedaPhor Limited and MedaPhor North America
Inc. (collectively "MedaPhor"), announce that MedaPhor and SonoSim
Inc. and The Regents of the University of California have reached
an agreement in principle on a patent license and patent
infringement settlement. As a result, the parties will proceed to
formalize their agreement in writing, following which the lawsuit
between the parties will be dismissed.
The settlement will be satisfied from the existing cash
resources of the Group. The Company will provide a further update
on the settlement once all documents are finalised.
This announcement contains inside information which is disclosed
in accordance with the Market Abuse Regulations which came into
effect on 3 July 2016.
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Cenkos Securities Tel: +44 (0)20 7397 8900
Bobbie Hilliam (Nominated
Adviser)
Julian Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com
Paul McManus / Anna Dunphy Mob: +44 (0)7980 541 893 / Mob: +44
(0)7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGGGPPPUPQUMQ
(END) Dow Jones Newswires
December 16, 2016 02:24 ET (07:24 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024